Ph.D., Sr. Director, Research & Development, Thermo Fisher
Biography
Currently, Robert Balog leads Thermo Fisher Scientific’s Microarray R&D team, responsible for developing next generation Microarray hardware, software, and assay workflows to support the clinical and research genomics markets. Prior to his current role he led the clinical system engineering team responsible for Thermo Fisher’s Amplitude High Throughput SARS-CoV-2 testing platform. Robert has over 15 years of experience in product development from basic biomarker discovery to on market support of diagnostic testing systems in both genomics and proteomics. Prior to Thermo Fisher, he spent 3 years as CEO and cofounder of BioCeryx developing automated microfluidic devices for noninvasive prenatal testing and 14 years as a Program Manager at SRI International developing host response IVDs for radiation exposure and integrated nucleic acid analysis systems. Dr. Balog has a Ph.D. in Biomedical Engineering from the University of Texas, Southwestern Medical Center at Dallas and a BE in Molecular Biology and Biomedical Engineering from Vanderbilt University.
Talk
Genomic Profiling Showcase:
Thermo Fisher
Thermo Fisher Scientific is the world leader in serving science. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
Advancing tools to drive Precision Medicine to Predictive Medicine
Learn how Thermo Fisher Scientific's Axiom technology is driving advances in precision medicine programs
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S1 - January 25 9.30 A.M.-3.00 P.M.,Showcase Track S1 - January 26 10.00 A.M.-10.15 A.M.,Showcase Track S1 - January 27 11.45 A.M.-12.00 P.M.
The PMWC 2023 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
